血管補片市場規模、佔有率及成長分析（按材料、應用及地區分類）－2026-2033年產業預測

預計到 2024 年，血管補片市場規模將達到 4.5258 億美元，到 2025 年將達到 4.8924 億美元，到 2033 年將達到 9.1228 億美元，預測期（2026-2033 年）的複合年成長率為 8.1%。

慢性腎臟病(CKD) 的高發生率對醫療保健環境造成了重大影響，並且是多種疾病的危險因素，包括糖尿病、高血壓和心血管疾病。 CKD 的特徵是腎功能逐漸下降，這會損害人體調節體液、電解質和代謝廢物的能力，從而導致嚴重的健康併發症。美國已有超過 3,700 萬成年人被診斷出患有此病，因此迫切需要有效的治療方法和介入措施。不斷成長的患者群體凸顯了對創新解決方案（例如血管補片）日益成長的需求，這些解決方案可以解決 CKD 相關併發症並改善患者預後。隨著醫療保健提供者尋求更先進的治療方案來控制 CKD併發症，血管補片市場預計將會成長。

全球血管補片市場按材料、應用和地區分類為三個部分。依材料分類，血管補片分為生物基血管補片和合成血管補片。依應用分類，血管補片分為頸動脈內膜剝離術、主動脈瘤、深部血管成形術和其他應用。依地區分類，血管補片市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲（MEA）。

血管補片市場成長要素

全球人口老化是血管補片市場成長的關鍵促進因素。隨著人口老化，罹患心血管疾病、高膽固醇、高血壓、中風、癌症和動脈瘤等多種健康問題的風險日益增加。這種人口結構變化導致對醫療干預的需求不斷成長，尤其是在心臟健康領域。老齡化與心血管健康下降之間的關聯凸顯了這一趨勢的重要性，也凸顯了開發血管補片等創新解決方案以應對人口老化帶來的日益嚴峻的健康挑戰的必要性，從而推動了市場發展。

血管補片市場的限制因素

血管補片市場成長面臨的關鍵阻礙因素之一是產品召回頻率的不斷增加，這引發了人們對產品品質和安全性的擔憂。例如，一些知名醫療公司也曾因可能危及病人安全的問題而召回血管補片。此類事件會引發醫護人員和病患的焦慮，導致他們對產品的信任度下降。因此，這些挑戰可能會對市場動態負面影響，損害消費者信心和整個產業的業績，並最終抑制血管補片市場的預期成長。

血管補片市場趨勢

血管補片市場呈現顯著上升趨勢，這主要得益於微創外科技術（尤其是經經皮冠狀動脈繞道手術 (MIDCAB) 等心血管手術）的日益普及。微創外科技術的進步提高了手術安全性，改善了病患預後，降低了死亡率，進而推動了這項改變。此外，與現有心肺體外迴圈系統相容的冠狀動脈血管支架等創新外科技術也推動了對血管移植片的需求。隨著醫療機構日益重視以患者為中心的治療方案和經濟高效的解決方案，預計血管補片市場將迎來強勁成長，這反映了醫療行業向先進外科手術和改善患者照護方向發展的趨勢。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究

全球血管補片市場規模（按材料和複合年成長率分類）（2026-2033 年）

• 生物衍生血管補片
• 合成血管補片

全球血管補片市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 頸動脈內膜剝離術
• 腹部主動脈血管瘤開放性修補術
• 血管繞道手術
• 先天性心臟疾病
• 其他用途

全球血管補片市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 門診手術中心

全球血管補片市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Baxter International Inc.（USA）
• Terumo Corporation（Japan）
• Edwards Lifesciences Corporation（USA）
• Getinge AB（Sweden）
• B. Braun SE（Germany）
• LeMaitre Vascular, Inc.（USA）
• WL Gore & Associates, Inc.（USA）
• Artivion, Inc.（formerly CryoLife, Inc.）（USA）
• Aziyo Biologics, Inc.（USA）
• Vascudyne, Inc.（USA）
• Collagen Solutions Plc（UK）
• FOC Medical SA（Switzerland）
• Obex Medical Ltd.（New Zealand）
• Vascumed（Pty）Ltd.（South Africa）
• Celox Medical（UK）
• Biom'up（France）
• Hemovent GmbH（Germany）
• Kuros Biosciences AG（Switzerland）
• Medtronic plc（Ireland）
• Abbott Laboratories（USA）

結論與建議

Vascular Patches Market size was valued at USD 452.58 Million in 2024 and is poised to grow from USD 489.24 Million in 2025 to USD 912.28 Million by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The prevalence of chronic kidney disease (CKD) significantly impacts the healthcare landscape, underpinning risks for various conditions such as diabetes, hypertension, and cardiovascular diseases. CKD is characterized by a gradual decline in kidney function, impairing the body's capability to regulate fluids, electrolytes, and waste, which can create serious health complications. With over 37 million adults in the United States diagnosed with this condition, the demand for effective treatments and interventions is crucial. This rising patient population highlights the increasing need for innovative solutions, such as vascular patches, that can address complications associated with CKD and improve patient outcomes. The market for vascular patches is poised for growth as healthcare providers seek advanced treatment options for managing CKD's ramifications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vascular Patches market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vascular Patches Market Segments Analysis

The global Vascular Patches Market is segmented into three segments i.e. by Material, Application and Region. Based on material, the market is segmented into Biologic Vascular Patches, Synthetic Vascular Patches. Based on Application, the market is segmented into Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, Other Applications. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver of the Vascular Patches Market

The increasing global aging population serves as a crucial driver for the growth of the vascular patches market. As individuals age, they are more susceptible to a variety of health issues, including cardiovascular diseases, high cholesterol, hypertension, strokes, cancer, and aneurysms. This demographic shift leads to a greater demand for medical interventions, particularly in cardiac health. The correlation between advancing age and the decline in cardiovascular wellness underscores the importance of this trend, highlighting the need for innovative solutions like vascular patches to address the escalating health challenges associated with an older population, thereby fostering market development.

Restraints in the Vascular Patches Market

One significant factor that may hinder growth in the vascular patches market is the increasing frequency of product recalls, which raises concerns about quality and safety. For example, notable healthcare companies have faced instances where vascular patches were recalled due to issues that could jeopardize patient safety. These events create apprehensions among healthcare providers and patients alike, potentially leading to decreased trust in these products. Consequently, such challenges can adversely affect market dynamics, influencing consumer confidence and the overall performance of the industry, ultimately restraining the anticipated growth of the vascular patches market.

Market Trends of the Vascular Patches Market

The Vascular Patches market is experiencing a notable upward trend driven by the rising adoption of minimally invasive surgical techniques, particularly in cardiac procedures such as MIDCAB. This shift is motivated by the enhanced safety and improved patient outcomes associated with these methods, leading to lower mortality rates. The compatibility of innovative surgical techniques, including coronary artery stent grafts, with existing cardiopulmonary bypass systems further propels demand for vascular grafts. As healthcare providers increasingly prioritize patient-centered approaches and economical solutions, the market for vascular patches is poised for robust growth, reflecting a broader movement toward advanced surgical interventions and improved patient care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Vascular Patches Market Size by Material & CAGR (2026-2033)

• Market Overview
• Biologic Vascular Patches
• Synthetic Vascular Patches

Global Vascular Patches Market Size by Application & CAGR (2026-2033)

• Market Overview
• Carotid Endarterectomy
• Open Repair of Abdominal Aortic Aneurysm
• Vascular Bypass Surgery
• Congenital Heart Disease
• Other Applications

Global Vascular Patches Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers

Global Vascular Patches Market Size & CAGR (2026-2033)

• North America (Material, Application, End User)
  • US
  • Canada
• Europe (Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc. (formerly CryoLife, Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aziyo Biologics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascudyne, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collagen Solutions Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FOC Medical S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Obex Medical Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascumed (Pty) Ltd. (South Africa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celox Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom'up (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemovent GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations